Similar articles for PMID: 19147513

Year	Number of Results
1998	1
2000	3
2001	1
2002	1
2003	3
2004	3
2005	7
2006	10
2007	12
2008	5
2009	5
2010	7
2011	4
2012	6
2013	2
2014	5
2015	6
2016	3
2017	6
2018	7
2019	6
2020	2
2021	4
2022	1
2024	0

1

RET/PTC rearrangement occurring in primary peritoneal carcinoma.

Flavin R, Jackl G, Finn S, Smyth P, Ring M, O'Regan E, Cahill S, Unger K, Denning K, Jinghuan Li, Aherne S, Tallini G, Gaffney E, O'Leary JJ, Zitzelsberger H, Sheils O. Flavin R, et al. Int J Surg Pathol. 2009 Jun;17(3):187-97. doi: 10.1177/1066896908329593. Epub 2009 Jan 14. Int J Surg Pathol. 2009. PMID: 19147513

2

[Molecular analysis of structural abnormalities in papillary thyroid carcinoma gene].

Vasil'ev EV, Rumiantsev PO, Saenko VA, Il'in AA, Poliakova EIu, Nemtsova MV, Zaletaev DV. Vasil'ev EV, et al. Mol Biol (Mosk). 2004 Jul-Aug;38(4):642-53. Mol Biol (Mosk). 2004. PMID: 15456136 Russian.

3

Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).

Carta C, Moretti S, Passeri L, Barbi F, Avenia N, Cavaliere A, Monacelli M, Macchiarulo A, Santeusanio F, Tartaglia M, Puxeddu E. Carta C, et al. Clin Endocrinol (Oxf). 2006 Jan;64(1):105-9. doi: 10.1111/j.1365-2265.2005.02401.x. Clin Endocrinol (Oxf). 2006. PMID: 16402937

4

Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.

Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X. Quiros RM, et al. Cancer. 2005 Jun 1;103(11):2261-8. doi: 10.1002/cncr.21073. Cancer. 2005. PMID: 15880523 Free article. Review.

5

Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.

Zhu Z, Ciampi R, Nikiforova MN, Gandhi M, Nikiforov YE. Zhu Z, et al. J Clin Endocrinol Metab. 2006 Sep;91(9):3603-10. doi: 10.1210/jc.2006-1006. Epub 2006 Jun 13. J Clin Endocrinol Metab. 2006. PMID: 16772343

6

High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.

Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA. Xu X, et al. Cancer Res. 2003 Aug 1;63(15):4561-7. Cancer Res. 2003. PMID: 12907632

7

Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.

Liu RT, Chou FF, Wang CH, Lin CL, Chao FP, Chung JC, Huang CC, Wang PW, Cheng JT. Liu RT, et al. Thyroid. 2005 Apr;15(4):326-35. doi: 10.1089/thy.2005.15.326. Thyroid. 2005. PMID: 15876154

8

[Frequency of RET/PTC rearrangement and somatic BRAF mutation in papillary thyroid cancer].

Rumiantsev PO, Zaletaev DV, Vasil'ev EV, Saenko VA, Il'in AA, Rumiantseva UV, Abrosimov AIu, Medvedev VS. Rumiantsev PO, et al. Vopr Onkol. 2006;52(2):145-9. Vopr Onkol. 2006. PMID: 17195637 Russian.

9

Molecular characteristics of papillary thyroid carcinomas without BRAF mutation or RET/PTC rearrangement: relationship with clinico-pathological features.

Durand S, Ferraro-Peyret C, Joufre M, Chave A, Borson-Chazot F, Selmi-Ruby S, Rousset B. Durand S, et al. Endocr Relat Cancer. 2009 Jun;16(2):467-81. doi: 10.1677/ERC-08-0081. Epub 2009 Feb 10. Endocr Relat Cancer. 2009. PMID: 19208736

10

Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.

Woodford RL, Nikiforov YE, Hunt JL, Bellizzi AM, Zhang X, Mills SE, Stelow EB. Woodford RL, et al. Am J Surg Pathol. 2010 Nov;34(11):1582-90. doi: 10.1097/PAS.0b013e3181f2d820. Am J Surg Pathol. 2010. PMID: 20924280

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year